Tasneem Khambaty1, Jesse C Stewart2, Samir K Gupta3, Chung-Chou H Chang4, Roger J Bedimo5, Matthew J Budoff6, Adeel A Butt7, Heidi Crane8, Cynthia L Gibert9, David A Leaf10, David Rimland11, Hilary A Tindle12, Kaku A So-Armah13, Amy C Justice14, Matthew S Freiberg15. 1. Department of Psychology, University of Miami, Coral Gables, Florida. 2. Department of Psychology, Indiana University-Purdue University Indianapolis, Indianapolis. 3. Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis. 4. Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 5. Department of Medicine, VA North Texas Health Care System, Dallas. 6. Los Angeles Biomedical Research Institute, Torrance, California. 7. VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania8Weill Cornell Medical College, Doha, Qatar, and New York, New York9Hamad Healthcare Quality Institute and Hamad Medical Corp, Doha, Qatar. 8. University of Washington School of Medicine, Seattle. 9. VA Medical Center, Washington, DC. 10. University of California, Los Angeles School of Medicine and Division of General Medicine, Greater Los Angeles VA Healthcare System, Los Angeles. 11. Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia. 12. Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. 13. Division of General Internal Medicine, Boston University, Boston, Massachusetts. 14. Department of Medicine, Yale University School of Medicine, and VA Connecticut Healthcare System, West Haven Affiliation, New Haven. 15. Cardiovascular Medicine Division, Vanderbilt University School of Medicine, Nashville, Tennessee18Tennessee Valley Geriatric Research Education and Clinical Center, Nashville.
Abstract
Importance: With the advent of highly effective antiretroviral therapy and improved survival, human immunodeficiency virus (HIV)-infected people are living longer and are now at an increased risk for cardiovascular disease (CVD). There is an urgent need to identify novel risk factors and primary prevention approaches for CVD in HIV. Although depression is prevalent in HIV-infected adults and is associated with future CVD in the general population, its association with CVD events has not been examined in the HIV-infected population. Objective: To examine whether depressive disorders are prospectively associated with incident acute myocardial infarction (AMI) in a large cohort of adults with HIV. Design, Setting, and Participants: Included in this cohort study were 26 144 HIV-infected veterans without CVD at baseline (1998-2003) participating in the US Department of Veterans Affairs Veterans Aging Cohort Study from April 1, 2003, through December 31, 2009. At baseline, 4853 veterans (19%) with major depressive disorder (MDD; International Classification of Diseases, Ninth Revision [ICD-9] codes 296.2 and 296.3) and 2296 (9%) with dysthymic disorder (ICD-9 code 300.4) were identified. The current analysis was conducted from January 2015 to November 2015. Main Outcomes and Measures: Incident AMI (defined by discharge summary documentation, enzyme/electrocardiography evidence of AMI, inpatient ICD-9 code for AMI (410), or AMI as underlying cause of death [International Statistical Classification of Diseases and Related Health Problems, Tenth Revision code 121]) between the enrollment date and December 31, 2009. Results: The mean (SD) age of those with MDD was 47.3 (7.9) years and for those without MDD was 48.2 (9.7) years. During 5.8 years of follow-up, 490 AMI events (1.9%) occurred. Baseline MDD was associated with incident AMI after adjusting for demographics (hazard ratio [HR], 1.31; 95% CI, 1.05-1.62), CVD risk factors (HR, 1.29; 95% CI, 1.04-1.60), and HIV-specific factors (HR, 1.30; 95% CI, 1.05-1.62). Further adjustment for hepatitis C, renal disease, substance abuse, and hemoglobin level (HR, 1.25; 95% CI, 1.00-1.56) and antidepressant use (HR, 1.12; 95% CI, 0.87-1.42) attenuated associations. Baseline dysthymic disorder was not associated with incident AMI. Conclusions and Relevance: We report novel evidence that HIV-infected adults with MDD have a 30% increased risk for AMI than HIV-infected adults without MDD after adjustment for many potential confounders. Our findings raise the possibility that MDD may be independently associated with incident atherosclerotic CVD in the HIV-infected population.
Importance: With the advent of highly effective antiretroviral therapy and improved survival, human immunodeficiency virus (HIV)-infectedpeople are living longer and are now at an increased risk for cardiovascular disease (CVD). There is an urgent need to identify novel risk factors and primary prevention approaches for CVD in HIV. Although depression is prevalent in HIV-infected adults and is associated with future CVD in the general population, its association with CVD events has not been examined in the HIV-infected population. Objective: To examine whether depressive disorders are prospectively associated with incident acute myocardial infarction (AMI) in a large cohort of adults with HIV. Design, Setting, and Participants: Included in this cohort study were 26 144 HIV-infected veterans without CVD at baseline (1998-2003) participating in the US Department of Veterans Affairs Veterans Aging Cohort Study from April 1, 2003, through December 31, 2009. At baseline, 4853 veterans (19%) with major depressive disorder (MDD; International Classification of Diseases, Ninth Revision [ICD-9] codes 296.2 and 296.3) and 2296 (9%) with dysthymic disorder (ICD-9 code 300.4) were identified. The current analysis was conducted from January 2015 to November 2015. Main Outcomes and Measures: Incident AMI (defined by discharge summary documentation, enzyme/electrocardiography evidence of AMI, inpatient ICD-9 code for AMI (410), or AMI as underlying cause of death [International Statistical Classification of Diseases and Related Health Problems, Tenth Revision code 121]) between the enrollment date and December 31, 2009. Results: The mean (SD) age of those with MDD was 47.3 (7.9) years and for those without MDD was 48.2 (9.7) years. During 5.8 years of follow-up, 490 AMI events (1.9%) occurred. Baseline MDD was associated with incident AMI after adjusting for demographics (hazard ratio [HR], 1.31; 95% CI, 1.05-1.62), CVD risk factors (HR, 1.29; 95% CI, 1.04-1.60), and HIV-specific factors (HR, 1.30; 95% CI, 1.05-1.62). Further adjustment for hepatitis C, renal disease, substance abuse, and hemoglobin level (HR, 1.25; 95% CI, 1.00-1.56) and antidepressant use (HR, 1.12; 95% CI, 0.87-1.42) attenuated associations. Baseline dysthymic disorder was not associated with incident AMI. Conclusions and Relevance: We report novel evidence that HIV-infected adults with MDD have a 30% increased risk for AMI than HIV-infected adults without MDD after adjustment for many potential confounders. Our findings raise the possibility that MDD may be independently associated with incident atherosclerotic CVD in the HIV-infected population.
Authors: Jessica R White; Chung-Chou H Chang; Kaku A So-Armah; Jesse C Stewart; Samir K Gupta; Adeel A Butt; Cynthia L Gibert; David Rimland; Maria C Rodriguez-Barradas; David A Leaf; Roger J Bedimo; John S Gottdiener; Willem J Kop; Stephen S Gottlieb; Matthew J Budoff; Tasneem Khambaty; Hilary A Tindle; Amy C Justice; Matthew S Freiberg Journal: Circulation Date: 2015-09-10 Impact factor: 29.690
Authors: Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek Journal: J Infect Dis Date: 2011-01-20 Impact factor: 5.226
Authors: Amy C Justice; Elizabeth Dombrowski; Joseph Conigliaro; Shawn L Fultz; Deborah Gibson; Tamra Madenwald; Joseph Goulet; Michael Simberkoff; Adeel A Butt; David Rimland; Maria C Rodriguez-Barradas; Cynthia L Gibert; Kris Ann K Oursler; Sheldon Brown; David A Leaf; Matthew B Goetz; Kendall Bryant Journal: Med Care Date: 2006-08 Impact factor: 2.983
Authors: Matthew S Freiberg; Chung-Chou H Chang; Lewis H Kuller; Melissa Skanderson; Elliott Lowy; Kevin L Kraemer; Adeel A Butt; Matthew Bidwell Goetz; David Leaf; Kris Ann Oursler; David Rimland; Maria Rodriguez Barradas; Sheldon Brown; Cynthia Gibert; Kathy McGinnis; Kristina Crothers; Jason Sico; Heidi Crane; Alberta Warner; Stephen Gottlieb; John Gottdiener; Russell P Tracy; Matthew Budoff; Courtney Watson; Kaku A Armah; Donna Doebler; Kendall Bryant; Amy C Justice Journal: JAMA Intern Med Date: 2013-04-22 Impact factor: 21.873
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: Hypertension Date: 2003-12-01 Impact factor: 10.190
Authors: Adeel A Butt; Shawn L Fultz; C Kent Kwoh; David Kelley; Melissa Skanderson; Amy C Justice Journal: Hepatology Date: 2004-07 Impact factor: 17.425
Authors: K So-Armah; S K Gupta; S Kundu; J C Stewart; J L Goulet; A A Butt; J J Sico; V C Marconi; S Crystal; M C Rodriguez-Barradas; M Budoff; C L Gibert; C-Ch Chang; R Bedimo; M S Freiberg Journal: HIV Med Date: 2019-03-29 Impact factor: 3.180
Authors: Triin Umbleja; Todd T Brown; Edgar T Overton; Heather J Ribaudo; Jennifer A Schrack; Kathleen V Fitch; Pamela S Douglas; Steven K Grinspoon; Sarah Henn; Roberto C Arduino; Benigno Rodriguez; Constance A Benson; Kristine M Erlandson Journal: J Infect Dis Date: 2020-07-09 Impact factor: 5.226
Authors: Brian W Pence; Jon C Mills; Angela M Bengtson; Bradley N Gaynes; Tiffany L Breger; Robert L Cook; Richard D Moore; David J Grelotti; Conall O'Cleirigh; Michael J Mugavero Journal: JAMA Psychiatry Date: 2018-04-01 Impact factor: 21.596
Authors: Alex Dregan; Lauren Rayner; Katrina A S Davis; Ioannis Bakolis; Jorge Arias de la Torre; Jayati Das-Munshi; Stephani L Hatch; Robert Stewart; Matthew Hotopf Journal: JAMA Psychiatry Date: 2020-06-01 Impact factor: 21.596
Authors: Cherise Wong; Stephen J Gange; Richard D Moore; Amy C Justice; Kate Buchacz; Alison G Abraham; Peter F Rebeiro; John R Koethe; Jeffrey N Martin; Michael A Horberg; Cynthia M Boyd; Mari M Kitahata; Heidi M Crane; Kelly A Gebo; M John Gill; Michael J Silverberg; Frank J Palella; Pragna Patel; Hasina Samji; Jennifer Thorne; Charles S Rabkin; Angel Mayor; Keri N Althoff Journal: Clin Infect Dis Date: 2018-04-03 Impact factor: 9.079
Authors: Natalie E Chichetto; Brittanny M Polanka; Kaku A So-Armah; Minhee Sung; Jesse C Stewart; John R Koethe; E Jennifer Edelman; Hilary A Tindle; Matthew S Freiberg Journal: Curr HIV/AIDS Rep Date: 2020-08 Impact factor: 5.495
Authors: Natalie E Chichetto; Suman Kundu; Matthew S Freiberg; John R Koethe; Adeel A Butt; Stephen Crystal; Kaku A So-Armah; Robert L Cook; R Scott Braithwaite; Amy C Justice; David A Fiellin; Maria Khan; Kendall J Bryant; Julie R Gaither; Shirish S Barve; Kristina Crothers; Roger J Bedimo; Alberta Warner; Hilary A Tindle Journal: AIDS Behav Date: 2021-06-08
Authors: Jesse C Stewart; Brittanny M Polanka; Kaku A So-Armah; Jessica R White; Samir K Gupta; Suman Kundu; Chung-Chou H Chang; Matthew S Freiberg Journal: Psychosom Med Date: 2020-06 Impact factor: 3.864
Authors: Kaku So-Armah; Laura A Benjamin; Gerald S Bloomfield; Matthew J Feinstein; Priscilla Hsue; Benson Njuguna; Matthew S Freiberg Journal: Lancet HIV Date: 2020-04 Impact factor: 16.070